Sole Source - Production of ChAdOx-1 and MVA expressing mouse gp70
Key Takeaways
- Full and open competition - all businesses eligible to bid
- Work to be performed in Bethesda, MD
- Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Contract Details
- Notice ID
- 75N98026Q00996
- Opportunity Type
- Combined Synopsis/Solicitation
- Sub-Agency
- NATIONAL INSTITUTES OF HEALTH
- Office
- NIH NCI
- Posted Date
- Thursday, August 20, 2026
- Response Deadline
- Monday, August 24, 2026
- PSC Code
- R416
- Set-Aside
- Full & Open Competition
- Place of Performance
- Bethesda, MD, 20892
- Status
- Active
Description
AMENDMENT #1: This amendment is posted to provide an answer to a question submitted in response to this notice. Question: We would like to know if this is a brand new contract OR if there is (was) an incumbent performing these services. Government Response: This is a new requirement. Title: Production of ChAdOx-1 and MVA expressing mouse gp70 Document type: Combined Synopsis/Intent to Sole Source Solicitation Number: RFQ# 75N98026Q00996 Proposed Post Date: 08/12/2026 Proposed Response Date: 08/19/2026 NAICS Code: 541714 Small Business Size Standard: 1,000 Contracting Office Address: Department of Health and Human Services, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20817 USA. Description: The National Cancer Centers (NCI) Laboratory of Integrative Cancer Immunology B
Why This Opportunity Matters
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is actively seeking qualified contractors for research and development in biotechnology (except nanobiotechnology) in Bethesda, MD.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
